Clinical trial
LEadless Advanced Pacing 2 Chronic Early Feasibility Study
NCT07287423 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LEadless Advanced Pacing 2 Chronic Early Feasibility Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 13, 2025
- Completion date
- December 31, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bradycardia, cardiac pacemaker, cardiac rhythm disorder